Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
about
Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.Emerging pharmaceutical therapies for COPD.Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink.The Reemergence of the Asthma-COPD Overlap Syndrome: Characterizing a Syndrome in the Precision Medicine Era.Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.Year in review 2016: Chronic obstructive pulmonary disease and asthma.A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis.Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.Eosinophils and eosinophil-associated diseases: An update.Blood Leukocyte Concentrations, FEV1 Decline, and Airflow Limitation. A 15-Year Longitudinal Study of World Trade Center-exposed Firefighters.Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts.Update in Chronic Obstructive Pulmonary Disease 2016.Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.A Light in the Darkness? The FLAME Trial, Blood Eosinophils, and Chronic Obstructive Pulmonary Disease.Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.Are blood eosinophils a prime-time biomarker for COPD management decisions?Risk factors for respiratory hospitalizations in a population of patients with a clinical diagnosis of COPD.Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add?Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease.Eosinophil counts in first COPD hospitalizations: a comparison of health service utilizationA Revised Treatment Approach for Hospitalized Patients with Eosinophilic and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary DiseaseEosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, CanadaHealth characteristics of patients with asthma, COPD and asthma-COPD overlap in the NHANES databaseClinical features, bacteriology of endotracheal aspirates and treatment outcomes of patients with chronic obstructive pulmonary disease and community-acquired pneumonia in an intensive care unit in Taiwan with an emphasis on eosinophilia versus non-eNeutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypesBurden of disease associated with a COPD eosinophilic phenotypeCirculating eosinophil levels do not predict severe exacerbations in COPD: a retrospective studyBlood biomarkers as predictors of long-term mortality in COPD
P2860
Q36302882-6A6BC874-48D8-4FD8-9E49-BD3D3FF76283Q37283465-1FCE9BDD-6DBB-4C7A-822B-5EF3ABCAEF90Q38598991-ADE75380-BA49-4A9D-9B3B-210FBEE1B5EDQ38645203-5B2DBB22-B677-4F13-9132-96A24720EBD6Q38685218-13577178-B324-4BE3-B07E-707E79B11647Q38751378-62AE47CB-0570-44A9-B1B3-2AEA2528AF49Q38802244-CC6800DF-85AC-45EA-B50C-7B973E07BE91Q38901257-50B39A5A-572C-499A-B956-8C2362C533D8Q39216404-52BDC7D5-9F88-4558-8CC3-5B0615F3E99DQ40092329-F635C142-1B6D-41C2-9C19-E9E3B6678D86Q40598255-4420AFD9-BA40-44A6-9F2C-553420F3DED1Q42358548-908B22A8-2471-47D1-815F-01A86B24A09CQ42677837-ECF722C4-9FAF-41D1-942D-E9DD2B1299D5Q46434748-F2F087DF-A3E4-4DA9-9E4F-A8999C878031Q47138049-73CE0678-D4B0-4E9A-985D-43922F46517CQ47555172-5CB0E575-3940-4F8A-BF42-0EE418D3C0EDQ47566949-910442B2-3346-45D8-A10E-2CB36956EA1EQ47666470-68933D9D-DDEF-46D5-AAD8-D02EBB3907D2Q47718704-039C25E3-A333-4F4D-AC72-66DA533F353BQ47724396-086D8F81-AAC0-4AC8-874A-94F5902CEC99Q48272082-ECADF396-103D-40CE-AB48-27043B222FE6Q48343913-9BC41263-F32C-4556-8C24-1EE876423CC3Q49751199-0C3FA8AE-12CD-4EB4-A8E8-D865E13AD834Q51825585-ED91145D-16B0-4903-8048-6430147FE7E0Q54979460-A2CC9D7A-7C92-4946-B22D-61E5E4CEB21BQ55007014-8D4278AE-426A-4EB2-AAED-2E964ED40963Q55235380-C0758969-55E7-42E5-B986-658AAD581C33Q55374810-ED3133ED-FD9B-4F52-AC44-ACAFC38971CCQ55387022-8E15C47E-A1C6-4289-A1F1-C48363B09EA0Q55415106-647E778F-6C59-40BB-B1C4-6DF3644D3173Q55686933-C5BF7419-F4BD-4C75-B55A-AB9BCDF2E2ECQ57487081-DA8EFA82-3783-4D68-84E5-A0CF2CA6F63DQ57493562-07345152-3E95-421D-B34C-E379690B3474Q57817679-352220D2-068E-409F-BE7E-34B63429EA42Q58746630-9F357C1A-B8A2-48E2-A1B7-AABA055AC236Q58750021-D13EFA3F-E760-487F-A2A1-44FFF60AD4A8Q58764884-28284C6E-BD5E-412F-8365-F1B53166E6FDQ58785955-6CF16D28-81FE-4091-A71D-8E0E90C5FA69Q58802553-FF53B465-4F34-4F4E-BA62-56AC452E2A32Q58856101-E3195919-75FD-48F0-B130-234E5A71212C
P2860
Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Blood Eosinophils and Exacerba ...... agen General Population Study.
@en
type
label
Blood Eosinophils and Exacerba ...... agen General Population Study.
@en
prefLabel
Blood Eosinophils and Exacerba ...... agen General Population Study.
@en
P2093
P2860
P1476
Blood Eosinophils and Exacerba ...... agen General Population Study.
@en
P2093
Jørgen Vestbo
Peter Lange
Signe Vedel-Krogh
Sune F Nielsen
P2860
P304
P356
10.1164/RCCM.201509-1869OC
P407
P577
2015-12-07T00:00:00Z